Thierry Delaunoit
Jolimont, WAL, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Adjuvant Aspirin Treatment in PIK3CA-Mutated Colon Cancer Patients: The SAKK 41/13 Prospective Randomized Placebo-Controlled Double-Blind Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 05, 2024
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
Journal: Clinical colorectal cancer
Published: April 09, 2021
Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor: a case report.
Journal: BMC gastroenterology
Published: April 24, 2020
Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 06, 2020
Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.
Journal: Cancer medicine
Published: April 03, 2020
Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Journal: BMC cancer
Published: July 26, 2018
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor.
Journal: Oncotarget
Published: June 08, 2017
Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept.
Journal: Minerva chirurgica
Published: January 16, 2016
Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer.
Journal: British journal of cancer
Published: December 04, 2015
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 30, 2015
The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer.
Journal: PloS one
Published: August 06, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 28, 2015
Last Updated: 09/26/2026